EL
PFE icon

ERN LLC’s Pfizer PFE Stock Holding History

ERN LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.83M Buy
+35,000
New +$1.78M 2.05% 15

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ERN LLC's PFE Position: Q2 2022 in Review

ERN LLC opened a new position in Pfizer (PFE) in Q2 2022: 35,000 shares worth $1.83M. The stake represents 2.05% of the portfolio and ranks #15 among its holdings.

3,160 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • ERN LLC held 35,000 shares of Pfizer worth $1.83M as of Q2 2022.
  • Pfizer was a new ERN LLC position in Q2 2022.
  • Pfizer made up 2.05% of ERN LLC's portfolio in Q2 2022, its #15 holding.
  • 3,160 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on ERN LLC's 13F filing for Q2 2022, filed 13 Jul 2022.